The United States will resume funding HIV, tuberculosis, malaria and polio medicine and the salaries of health workers directly delivering most of these services to patients through bilateral deals with governments and faith-based organizations– at least for the 2026 financial year, according to the America First Global Health Strategy unveiled by the US State Department […] Continue reading ->
For every $1 invested in cost-effective “best buys” to prevent non-communicable diseases (NCDs) over the next five years, there would be a four-fold return in social and economic benefits, according to the World Health Organization (WHO). The WHO’s 29 “best buys” focus on reducing tobacco and alcohol consumption, addressing unhealthy diets and lack of exercise, […] Continue reading ->
The final political declaration for the United Nations High-Level Meeting (HLM) on NCDs is substantially weaker than the zero draft, no longer referring to taxing sugar-sweetened beverages – while describing higher taxes on tobacco and alcohol as “considerations… in line with national circumstances” rather than concrete proposals. However, targets for reducing tobacco use and increasing […] Continue reading ->
Regulating pharmaceutical companies that manufacture essential health products during a public health emergency is a key flashpoint between developed and developing countries ahead of the final round of talks on the pandemic agreement. This is evident in some of the 17 submissions made to the Intergovernmental Negotiating Working Group (IGWG), which is coordinating the final […] Continue reading ->